CABERGOLINE ZENTIVA 0.5 mg, scored tablet 8 tablets
Active ingredients: Cabergoline
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet8 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CABERGOLINE ZENTIVA 0,5 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 8 comprimé(s)
- Marketing authorisation holder
- RENATA PHARMACEUTICALS (IRELAND) (IRLANDE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65266671CIP73030339CIP133400930303399Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CABERGOLINEcomprimé | 0,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.